Read more

January 27, 2020
3 min read
Save

Positive ECG, negative echocardiography may identify patients with elevated cardiac risk

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Melissa A. Daubert

Patients with positive ECG results and normal stress echocardiography had a slightly increased risk for adverse cardiac events, according to a study published in JAMA Internal Medicine.

Perspective from Christopher M. Kramer, MD

“These findings add significantly to the current knowledge base,” Melissa A. Daubert, MD, associate professor of medicine at Duke University School of Medicine, member in the Duke Clinical Research Institute and Cardiology Today Next Gen Innovator, told Healio. “First, this study has identified an ‘at-risk’ population that is commonly encountered in clinical practice, but has been underrecognized and not well characterized. Second, previous studies have been either too small or too short in duration to definitively differentiate +ECG/–Echo patients from –ECG/–Echo patients, and thus until now, these populations have been considered to have an equivalent prognosis with a similar benign clinical trajectory. This study demonstrates that patients with +ECG/–Echo are at higher risk for adverse outcomes.”

Exercise stress echocardiography

Researchers analyzed data from 15,077 patients (mean age, 52 years; 41% men) who were free from CAD who underwent exercise stress echocardiography between January 2000 and February 2014. The primary outcome was a composite endpoint of major adverse cardiac events, defined as MI, all-cause death, coronary revascularization and hospitalization for unstable angina. Secondary endpoints were defined as downstream testing and individual adverse event rates.

Of the patients in the study, 85.5% had a negative ECG and negative echocardiography, 8.5% had positive ECG and negative echocardiography and 6% had positive echocardiography.

During a median follow-up of 7.3 years, the composite endpoint occurred in 8.5% of patients with a negative ECG and negative echocardiography, 14.6% of those with a positive ECG and negative echocardiography and 37.4% of patients with positive echocardiography. In addition, death occurred in 4.8% of patients with a negative ECG and negative echocardiography, 5.9% of those with a positive ECG and negative echocardiography and 11.2% of patients with positive echocardiography. MI was observed in 2.2% of patients with a negative ECG and negative echocardiography, 3.6% of those with a positive ECG and negative echocardiography and 8.7% of patients with positive echocardiography.

Adding stress ECG findings to exercise and clinical data resulted in incremental prognostic value, according to the study.

The least downstream testing was performed in patients with a negative ECG and negative echocardiography (2.3%), followed by those with a positive ECG and negative echocardiography (12.8%) and patients with positive echocardiography (33.6%; P < .001).

PAGE BREAK

Implications for clinical practice

“We have identified a population with increased cardiac risk that until now were not well defined and unknowingly grouped with a lower-risk cohort, which obscured the prognostic significance of +ECG/–Echo,” Daubert said in an interview. “These findings have ramifications for the dissemination of clinical results. ... By recognizing that +ECG/–Echo patients are at increased cardiac risk, there is an opportunity to intervene and potentially decrease adverse outcomes in this population.” – by Darlene Dobkowski

For more information:

Melissa A. Daubert, MD, can be reached at Duke Clinical Research Institute, 200 Morris St., Durham, NC 27701; email: melissa.daubert@duke.edu.

Disclosures: Daubert reports no relevant financial disclosures. Please see the study for all other authors’ relevant financial disclosures.